(-)-5-Me-8-OH-DPAT, a new silent and full 5-HT1A receptor antagonist

被引:0
|
作者
Trillat, AC
Mathé-Allainmat, M
Malagié, I
Jacquot, C
Langlois, M
Gardier, AM
机构
[1] Univ Paris Sud, Fac Pharm, Neuropharmacol Lab, F-92296 Chatenay Malabry, France
[2] Univ Paris Sud, Fac Pharm, BIOCIS, CNRS,URA 1843,Lab Reconnaissance Mol & Cellulaire, F-92296 Chatenay Malabry, France
[3] Univ Paris Sud, Fac Pharm, IFR, Inst Signalisat & Innovat Therapeut, F-92296 Chatenay Malabry, France
[4] Fac Picardie Jules Verne, F-80030 Amiens, France
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P814
引用
收藏
页码:R106 / R106
页数:1
相关论文
共 50 条
  • [31] INTRACEREBRAL ACTIONS OF THE 5-HT1A AGONISTS, 8-OH-DPAT AND BUSPIRONE AND OF THE 5-HT1A PARTIAL AGONIST ANTAGONIST, NAN-190, ON FEMALE SEXUAL-BEHAVIOR
    UPHOUSE, L
    CALDAROLAPASTUSZKA, M
    MONTANEZ, S
    NEUROPHARMACOLOGY, 1992, 31 (10) : 969 - 981
  • [32] Effect of 5-HT1A receptor agonist, 8-OH-DPAT, on cough responses in the conscious guinea pig
    Stone, RA
    Barnes, PJ
    Chung, KF
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 332 (02) : 201 - 207
  • [33] The 5-HT1A, receptor agonist 8-OH-DPAT reduces apoptotic damage in cultured CNS cells
    Ahlemeyer, B
    Semkova, I
    Widing, E
    Krieglstein, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R94 - R94
  • [34] Adrenaline release by the 5-HT1A receptor agonist 8-OH-DPAT is partly responsible for pituitary activation
    Korte, SM
    Buwalda, B
    DeKloet, ER
    Bohus, B
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 309 (03) : 281 - 286
  • [35] Stereoselectivity of 8-OH-DPAT toward the serotonin 5-HT1A receptor:: Biochemical and molecular modeling study
    Dabrowska, Joanna
    Brylinski, Michal
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (04) : 498 - 511
  • [36] Effects of the 5-HT1A receptor agonists buspirone and 8-OH-DPAT on pupil size in common marmosets
    Kotani, Manato
    Urushino, Naoko
    Natsutani, Itaru
    Ogi, Yuji
    Ikeda, Kazuhito
    BEHAVIOURAL PHARMACOLOGY, 2017, 28 (04): : 313 - 317
  • [37] Effects of a 5-HT1A receptor agonist (8-OH-DPAT) and antagonist (WAY-100635) on free-operant timing behaviour
    Body, S
    Kheramin, S
    Mobini, S
    Ho, MY
    Velazquez-Martínez, DN
    Bradshaw, CM
    Szabadi, E
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A25 - A25
  • [38] THE EFFECTS OF WAY-100635, A POTENT AND SELECTIVE 5-HT1A RECEPTOR ANTAGONIST, ON FEEDING AND 8-OH-DPAT-INDUCED FEEDING IN THE RAT
    HARTLEY, JE
    FORSTER, EA
    FLETCHER, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U151 - U151
  • [39] The 5-HT1A receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits
    Chidlow, G
    Nash, MS
    De Santis, LM
    Osborne, NN
    EXPERIMENTAL EYE RESEARCH, 1999, 69 (06) : 587 - 593
  • [40] The role of genotype in the effects of chronic 5-HT1A receptor activation with the selective agonist 8-OH-DPAT
    Il'chibaeva, T. V.
    Tsybko, A. S.
    Naumenko, V. S.
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2015, 47 : 35 - 35